TOMMASINI, Silvana
 Distribuzione geografica
Continente #
NA - Nord America 4.255
EU - Europa 3.576
AS - Asia 1.986
SA - Sud America 1.080
AF - Africa 65
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.976
Nazione #
US - Stati Uniti d'America 4.206
IE - Irlanda 1.007
BR - Brasile 984
SE - Svezia 842
SG - Singapore 603
CN - Cina 584
UA - Ucraina 493
HK - Hong Kong 393
DE - Germania 374
IT - Italia 198
FI - Finlandia 195
GB - Regno Unito 189
VN - Vietnam 142
IN - India 70
AT - Austria 60
FR - Francia 46
RU - Federazione Russa 45
PL - Polonia 44
AR - Argentina 28
TR - Turchia 28
IQ - Iraq 23
MA - Marocco 20
MX - Messico 20
CA - Canada 19
UZ - Uzbekistan 19
BD - Bangladesh 18
BE - Belgio 18
CZ - Repubblica Ceca 16
IR - Iran 16
VE - Venezuela 16
EC - Ecuador 15
ZA - Sudafrica 15
PK - Pakistan 12
AZ - Azerbaigian 11
TN - Tunisia 10
CL - Cile 9
CO - Colombia 9
KE - Kenya 9
NL - Olanda 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
IL - Israele 7
JP - Giappone 7
ID - Indonesia 6
OM - Oman 6
PE - Perù 6
LV - Lettonia 5
PY - Paraguay 5
RS - Serbia 5
EG - Egitto 4
EU - Europa 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
AL - Albania 3
DZ - Algeria 3
ES - Italia 3
JO - Giordania 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
GE - Georgia 2
GR - Grecia 2
LT - Lituania 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.976
Città #
Dublin 1.007
Jacksonville 946
Chandler 659
Nyköping 502
Hong Kong 392
Singapore 349
Beijing 228
Dearborn 203
Ashburn 170
Princeton 166
Cambridge 161
Medford 152
Dong Ket 140
Des Moines 120
Boardman 109
The Dalles 103
Ann Arbor 83
Messina 81
Lancaster 69
São Paulo 60
Jinan 58
Vienna 57
Woodbridge 51
Wilmington 49
Los Angeles 46
San Mateo 41
Shenyang 40
Pune 37
Warsaw 37
Rio de Janeiro 32
New York 31
Tianjin 30
Belo Horizonte 28
Munich 28
Helsinki 27
Nanjing 26
Brasília 25
Hangzhou 24
Augusta 22
Bremen 20
Nanchang 20
Haikou 19
Brussels 18
Leawood 18
Tashkent 18
Campinas 17
Frankfurt am Main 15
Hebei 14
Porto Alegre 14
Zhengzhou 14
Brno 13
Curitiba 13
Ningbo 12
Ardabil 11
Baku 11
Nuremberg 10
Salvador 10
Seattle 10
Bexley 9
Edinburgh 9
Guangzhou 9
Guarulhos 9
Hyderabad 9
Nairobi 9
Taiyuan 9
Auburn Hills 8
Baghdad 8
Fuzhou 8
Houston 8
Jiaxing 8
London 8
Manaus 8
Montevideo 8
Norwalk 8
Ottawa 8
Saint Petersburg 8
Taizhou 8
Turku 8
Washington 8
Betim 7
Brooklyn 7
Casablanca 7
Dhaka 7
Fortaleza 7
Francofonte 7
Johannesburg 7
Monmouth Junction 7
Osasco 7
Seropédica 7
Wroclaw 7
Agrigento 6
Atlanta 6
Catania 6
Caxias do Sul 6
Clearwater 6
Cotia 6
Goiânia 6
Joinville 6
Muscat 6
Nova Iguaçu 6
Totale 6.978
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 180
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 153
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 122
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 116
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 99
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 93
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 92
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 91
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 91
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 91
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 89
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 89
Analytical profile and release of lonidamine from pharmaceutical formulation 89
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 89
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 89
Anticonvulsant agent: enhancement of physicochemical properties 88
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 86
Nanotherapeutics for anti-inflammatory delivery 86
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 85
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 85
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 85
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 84
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 83
B-Cyclodextrin conjugates for sustained release of drugs 83
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 83
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 83
Chitosan nanospheres containing cyclodextrins for idebenone delivery 83
Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation 83
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 82
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 82
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 81
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 80
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 80
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 79
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 79
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 79
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 79
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 79
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 78
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 78
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 78
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 78
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 78
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 77
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 77
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 76
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 76
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 75
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 75
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 75
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 74
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 74
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 74
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 73
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 73
Biodegradable microparticles as carrier for moxifloxacine 71
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 71
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 71
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 71
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 71
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 70
Determination of fludarabine in a pharmaceutical formulation by LC 70
Solid-state study of polymorphic drugs: carbamazepine 69
THE COORDINATION CHEMISTRY OF 1,4 BENZODIAZEPINES.HEAVY METAL COMPLEXES OF PSYCOTHERAPEUTIC DRUGS. 69
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 69
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 69
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 68
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 68
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 68
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 67
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 67
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation 67
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 67
MOXIFLOXACIN-LOADED CHITOSAN MICROSPHERES FOR INTRAPULMONARY ADMINISTRATION 66
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 66
METODI PER LA VALUTAZIONE DIMENSIONALE DI PARTICELLE DI POLVERI DI IMPIEGO FARMACEUTICO.Nota IV. 66
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 66
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 66
Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells 65
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 65
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 65
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 65
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 65
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 64
Celecoxib-loaded PLGA/cyclodextrin microspheres: Characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures 64
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 63
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 63
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 62
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 62
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 62
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 62
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 62
Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin 62
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 62
Gemcitabine anticancer activity enhancement by water soluble celecoxib/ sulfobutyl ether-β-cyclodextrin inclusion complex 62
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 62
Study of the inclusion complex of atenolol with beta- cyclodextrins 61
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 61
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 60
USE OF DIFFERENT CYCLODEXTRINS AS SOLUBILIZING AGENTS 60
Totale 7.711
Categoria #
all - tutte 42.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 0 0 0 15
2020/20211.215 151 4 263 35 24 139 8 136 34 110 129 182
2021/20221.116 26 203 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024547 76 105 52 66 53 116 12 21 0 15 2 29
2024/20252.967 48 51 59 192 113 67 40 694 756 187 283 477
Totale 11.096